# FDA Inspection 1180553 - AvKARE - August 23, 2022

Source: https://www.keypedia.com/records/fda_inspections/avkare/61f6b4d6-5b89-4642-ab9c-e95fef3ff534
Source feed: FDA_Inspections

> FDA Inspection 1180553 for AvKARE on August 23, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1180553
- Company Name: AvKARE
- Inspection Date: 2022-08-23
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1187248 - 2022-11-02](https://www.keypedia.com/records/fda_inspections/avkare/7809c462-6e0a-4dc6-ba39-e45b7bf29fa7)
- [FDA Inspection 1031035 - 2017-06-06](https://www.keypedia.com/records/fda_inspections/avkare/0838507f-d22d-4a4e-a027-cba5d9a8242c)
- [FDA Inspection 883310 - 2014-06-09](https://www.keypedia.com/records/fda_inspections/avkare/f80a6cf9-ea9c-418d-91f3-31297afb878e)

Company: https://www.keypedia.com/companies/avkare/7412af8d-e223-4f5b-90f3-24a1cc0b3838

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c